nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Glimepiride—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Glimepiride—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Glimepiride—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Glimepiride—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Glimepiride—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00119	CcSEcCtD
Glimepiride—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Glimepiride—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Glimepiride—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Glimepiride—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00118	CcSEcCtD
Glimepiride—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00118	CcSEcCtD
Glimepiride—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Glimepiride—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Glimepiride—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00116	0.00117	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Glimepiride—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Glimepiride—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Glimepiride—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Glimepiride—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Glimepiride—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Glimepiride—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Glimepiride—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Glimepiride—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Glimepiride—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Glimepiride—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Glimepiride—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Glimepiride—Rash—Topotecan—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Glimepiride—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Glimepiride—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Glimepiride—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Headache—Topotecan—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Rash—Tretinoin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Glimepiride—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00111	0.00112	CcSEcCtD
Glimepiride—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Glimepiride—Headache—Tretinoin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Glimepiride—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Glimepiride—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Glimepiride—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Glimepiride—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Glimepiride—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Glimepiride—Rash—Melphalan—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Glimepiride—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0011	0.00111	CcSEcCtD
Glimepiride—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Glimepiride—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Glimepiride—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Glimepiride—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Glimepiride—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Glimepiride—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Glimepiride—Nausea—Topotecan—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Glimepiride—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Glimepiride—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Glimepiride—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Glimepiride—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Glimepiride—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Glimepiride—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Glimepiride—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Glimepiride—Nausea—Melphalan—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Glimepiride—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Glimepiride—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Glimepiride—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Glimepiride—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Glimepiride—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Glimepiride—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Glimepiride—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Glimepiride—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Glimepiride—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Glimepiride—Anorexia—Etoposide—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Glimepiride—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000997	0.000998	CcSEcCtD
Glimepiride—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000993	0.000994	CcSEcCtD
Glimepiride—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000992	0.000992	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00099	0.000991	CcSEcCtD
Glimepiride—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000984	0.000984	CcSEcCtD
Glimepiride—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000982	0.000982	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Glimepiride—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000966	0.000966	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000965	0.000965	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000958	0.000959	CcSEcCtD
Glimepiride—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000957	0.000957	CcSEcCtD
Glimepiride—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000956	0.000956	CcSEcCtD
Glimepiride—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000952	0.000953	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000949	0.000949	CcSEcCtD
Glimepiride—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000945	0.000946	CcSEcCtD
Glimepiride—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000945	0.000946	CcSEcCtD
Glimepiride—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000944	0.000944	CcSEcCtD
Glimepiride—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000943	0.000943	CcSEcCtD
Glimepiride—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000937	0.000937	CcSEcCtD
Glimepiride—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000934	0.000935	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000934	0.000934	CcSEcCtD
Glimepiride—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000931	0.000931	CcSEcCtD
Glimepiride—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000924	0.000924	CcSEcCtD
Glimepiride—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000923	0.000924	CcSEcCtD
Glimepiride—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000921	0.000922	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000916	0.000916	CcSEcCtD
Glimepiride—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000915	0.000916	CcSEcCtD
Glimepiride—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000913	0.000914	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00091	0.000911	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000907	0.000908	CcSEcCtD
Glimepiride—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000906	0.000906	CcSEcCtD
Glimepiride—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.0009	0.000901	CcSEcCtD
Glimepiride—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00089	0.000891	CcSEcCtD
Glimepiride—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000888	0.000888	CcSEcCtD
Glimepiride—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000885	0.000886	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000885	0.000886	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000875	0.000875	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000872	0.000873	CcSEcCtD
Glimepiride—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000866	0.000866	CcSEcCtD
Glimepiride—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000862	0.000863	CcSEcCtD
Glimepiride—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000862	0.000862	CcSEcCtD
Glimepiride—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000859	0.00086	CcSEcCtD
Glimepiride—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000858	0.000858	CcSEcCtD
Glimepiride—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000856	0.000856	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000855	0.000855	CcSEcCtD
Glimepiride—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000849	0.000849	CcSEcCtD
Glimepiride—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000848	0.000848	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000847	0.000848	CcSEcCtD
Glimepiride—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000845	0.000845	CcSEcCtD
Glimepiride—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000844	0.000844	CcSEcCtD
Glimepiride—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000843	0.000844	CcSEcCtD
Glimepiride—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000835	0.000835	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000833	0.000833	CcSEcCtD
Glimepiride—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000831	0.000831	CcSEcCtD
Glimepiride—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000829	0.000829	CcSEcCtD
Glimepiride—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000825	0.000825	CcSEcCtD
Glimepiride—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000823	0.000823	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000819	0.00082	CcSEcCtD
Glimepiride—Rash—Vincristine—peripheral nervous system neoplasm	0.000818	0.000818	CcSEcCtD
Glimepiride—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000817	0.000818	CcSEcCtD
Glimepiride—Headache—Vincristine—peripheral nervous system neoplasm	0.000813	0.000813	CcSEcCtD
Glimepiride—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000799	0.000799	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000797	0.000798	CcSEcCtD
Glimepiride—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000785	0.000785	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000784	0.000784	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000781	0.000781	CcSEcCtD
Glimepiride—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000774	0.000775	CcSEcCtD
Glimepiride—Nausea—Vincristine—peripheral nervous system neoplasm	0.00077	0.000771	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000767	0.000768	CcSEcCtD
Glimepiride—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000754	0.000754	CcSEcCtD
Glimepiride—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000743	0.000744	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000741	0.000741	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000739	0.00074	CcSEcCtD
Glimepiride—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000729	0.00073	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000725	0.000726	CcSEcCtD
Glimepiride—Rash—Cisplatin—peripheral nervous system neoplasm	0.000723	0.000724	CcSEcCtD
Glimepiride—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000723	0.000723	CcSEcCtD
Glimepiride—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000722	0.000722	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000722	0.000722	CcSEcCtD
Glimepiride—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000719	0.000719	CcSEcCtD
Glimepiride—Tension—Epirubicin—peripheral nervous system neoplasm	0.000708	0.000709	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000701	0.000701	CcSEcCtD
Glimepiride—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000695	0.000695	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000685	0.000686	CcSEcCtD
Glimepiride—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000681	0.000682	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00068	0.000681	CcSEcCtD
Glimepiride—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000668	0.000668	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000668	0.000668	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000668	0.000668	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000667	0.000667	CcSEcCtD
Glimepiride—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000663	0.000664	CcSEcCtD
Glimepiride—Rash—Etoposide—peripheral nervous system neoplasm	0.000663	0.000663	CcSEcCtD
Glimepiride—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000662	0.000662	CcSEcCtD
Glimepiride—Headache—Etoposide—peripheral nervous system neoplasm	0.000658	0.000659	CcSEcCtD
Glimepiride—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000655	0.000656	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000649	0.000649	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000646	0.000646	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000638	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000634	0.000635	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.00063	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000625	0.000626	CcSEcCtD
Glimepiride—Nausea—Etoposide—peripheral nervous system neoplasm	0.000624	0.000624	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000623	0.000623	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000617	0.000618	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.000614	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000612	0.000613	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000601	0.000601	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.000598	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000594	0.000594	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000587	0.000587	CcSEcCtD
Glimepiride—Shock—Epirubicin—peripheral nervous system neoplasm	0.000579	0.00058	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000579	0.000579	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000569	0.00057	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000567	0.000567	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000561	0.000562	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.000556	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00055	0.000551	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Glimepiride—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000534	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000525	0.000525	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.00052	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000519	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.00051	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000509	0.000509	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000493	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.00049	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000486	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000486	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000485	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000482	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.00048	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.000474	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.000446	CcSEcCtD
Glimepiride—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.000433	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Glimepiride—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000423	CcSEcCtD
Glimepiride—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Glimepiride—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Glimepiride—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000389	0.00039	CcSEcCtD
Glimepiride—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Glimepiride—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000375	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Glimepiride—Rash—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000372	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Glimepiride—Headache—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000361	CcSEcCtD
Glimepiride—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000347	CcSEcCtD
Glimepiride—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000344	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Glimepiride—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000342	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Glimepiride—Chlorpropamide—ABCB1—peripheral nervous system neoplasm	0.00032	0.597	CrCbGaD
Glimepiride—Glyburide—ABCB1—peripheral nervous system neoplasm	0.000216	0.403	CrCbGaD
